MINDMAP*Cancer-Study: Mechanisms of psychological change during therapy for breast cancer: a multidimensional approach

MINDMAP*Cancer-Study: Mechanisms of psychological change during therapy for breast cancer: a multidimensional approach - MINDMAP*Cancer-Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031720

Enrollment

150

Registered

2023-04-24

Start date

2023-11-10

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C50

Interventions

Group 1: Patients with an initial diagnosis of mastocarcinoma treated with immediate surgery will be repeatedly asked about their psychological well-being (see endpoints) during their oncological trea

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: suffient German language skills infoment, written consent acute initial diagnosis of breast cancer without minimun of size (change after amendment 15.02.2024)

Exclusion criteria

Exclusion criteria: any kind of dementia lifetime diagnosis of a major psychotic disorder

Design outcomes

Primary

Measure	Time frame
Health related life satisfaction measured by self-rating questionnaire Short-Form-Health-Survey-12 (SF-12) particularly subscale mental health during oncological treatment over 40 weeks (T0-T11).	—

Secondary

Measure	Time frame
Additional questionnaires assessing general anxiety using the Generalized Anxiety Disorder-7 (GAD-7), somatic symptoms using the Somatic Symptoms Disorder – B Criteria Scale-12, depressive symptoms using the Patient Health Questionnaire (PHQ-9) and impact of breast cancer treatment using FACT-B )Functional Assessment of Cancer Therapy) at (T0), T2, T4, T6, T8-11. Assessments T0, T4, T8 and T11 also include a questionnaire about the satisfaction with the treatment (Client Satisfaction Questionnaire, CSQ-8). Pyschological support for breast cancer will be assessed three at times.	—

Measure

Time frame

Additional questionnaires assessing general anxiety using the Generalized Anxiety Disorder-7 (GAD-7), somatic symptoms using the Somatic Symptoms Disorder – B Criteria Scale-12, depressive symptoms using the Patient Health Questionnaire (PHQ-9) and impact of breast cancer treatment using FACT-B )Functional Assessment of Cancer Therapy) at (T0), T2, T4, T6, T8-11. Assessments T0, T4, T8 and T11 also include a questionnaire about the satisfaction with the treatment (Client Satisfaction Questionnaire, CSQ-8). Pyschological support for breast cancer will be assessed three at times.

—

Countries

Germany

Contacts

Public ContactNele Assmann

Klinik für Psychiatrie und Psychotherapie des UKSH

nele.assmann@uksh.de+49 451 500 98758

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026